JP2022515885A5 - - Google Patents

Info

Publication number
JP2022515885A5
JP2022515885A5 JP2021538388A JP2021538388A JP2022515885A5 JP 2022515885 A5 JP2022515885 A5 JP 2022515885A5 JP 2021538388 A JP2021538388 A JP 2021538388A JP 2021538388 A JP2021538388 A JP 2021538388A JP 2022515885 A5 JP2022515885 A5 JP 2022515885A5
Authority
JP
Japan
Prior art keywords
independently
group
value
integer
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021538388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022515885A (ja
JP7657153B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000019 external-priority patent/WO2020141460A2/en
Publication of JP2022515885A publication Critical patent/JP2022515885A/ja
Publication of JP2022515885A5 publication Critical patent/JP2022515885A5/ja
Priority to JP2024178728A priority Critical patent/JP2025020144A/ja
Application granted granted Critical
Publication of JP7657153B2 publication Critical patent/JP7657153B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021538388A 2019-01-03 2020-01-02 切断可能なリンカーを含む化合物及びその使用 Active JP7657153B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024178728A JP2025020144A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962788039P 2019-01-03 2019-01-03
US62/788,039 2019-01-03
PCT/IB2020/000019 WO2020141460A2 (en) 2019-01-03 2020-01-02 Compounds comprising cleavable linker and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024178728A Division JP2025020144A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Publications (3)

Publication Number Publication Date
JP2022515885A JP2022515885A (ja) 2022-02-22
JP2022515885A5 true JP2022515885A5 (https=) 2023-01-19
JP7657153B2 JP7657153B2 (ja) 2025-04-04

Family

ID=71407384

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021538388A Active JP7657153B2 (ja) 2019-01-03 2020-01-02 切断可能なリンカーを含む化合物及びその使用
JP2024178728A Withdrawn JP2025020144A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024178728A Withdrawn JP2025020144A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Country Status (7)

Country Link
US (1) US12551570B2 (https=)
EP (1) EP3906063A4 (https=)
JP (2) JP7657153B2 (https=)
KR (1) KR20210099658A (https=)
CN (2) CN114306635A (https=)
EA (1) EA202191855A1 (https=)
WO (1) WO2020141460A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120682290A (zh) 2017-07-04 2025-09-23 尹图赛利有限公司 包含可裂解接头的化合物及其用途
KR20210099658A (ko) 2019-01-03 2021-08-12 주식회사 인투셀 절단가능 링커를 포함하는 화합물 및 이의 용도
WO2020232247A1 (en) 2019-05-14 2020-11-19 Provention Bio, Inc. Methods and compositions for preventing type 1 diabetes
IL298999A (en) 2020-06-11 2023-02-01 Provention Bio Inc Methods and compositions for the prevention of type 1 diabetes
JP2024520444A (ja) 2021-05-24 2024-05-24 プロヴェンション・バイオ・インコーポレイテッド 1型糖尿病を治療するための方法
CN114874287B (zh) * 2022-05-20 2024-04-02 联宁(苏州)生物制药有限公司 一种抗体偶联药物-连接子lnd1042的合成方法
WO2025252011A1 (zh) * 2024-06-03 2025-12-11 杭州多域生物技术有限公司 含Sulfoximine连接子的降解剂及其中间体和应用
CN119462688B (zh) * 2024-11-08 2026-03-10 青岛大学 一种生物素化氨基酸衍生物的制备方法
CN121494812A (zh) * 2026-01-14 2026-02-10 西南林业大学 一种基于肉桂酸衍生物的n2h4比率型荧光探针及其合成方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1182232B (de) 1963-03-08 1964-11-26 Hans J Zimmer Verfahrenstechni Verfahren zur Herstellung von Trialkylaryloxysilanen
CH565791A5 (https=) 1972-07-11 1975-08-29 Sandoz Ag
US4540828A (en) 1982-06-01 1985-09-10 Vista Chemical Company Catalysts for alkoxylation reactions
JPS5978171A (ja) 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
DE3632329A1 (de) 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
JP3041736B2 (ja) * 1991-11-01 2000-05-15 コニカ株式会社 ハロゲン化銀写真感光材料
ATE218132T1 (de) 1994-10-14 2002-06-15 Yamanouchi Pharma Co Ltd Azol-derivate
JP2005291974A (ja) * 2004-03-31 2005-10-20 Kyocera Chemical Corp フェルダジル基を有する磁性有機粒子、粒子固定方法及びマイクロアレイ
EP1867729A1 (en) 2006-06-14 2007-12-19 Libragen Water soluble phenolics derivatives with dermocosmetic and therapeutic applications
CN104185477B (zh) 2011-11-17 2017-05-24 辉瑞公司 细胞毒性肽及其抗体‑药物缀合物
TWI585115B (zh) 2011-12-15 2017-06-01 普利司通股份有限公司 經穩定之多價陰離子聚合反應引發劑及其製備方法
ES2781523T3 (es) 2012-07-12 2020-09-02 Hangzhou Dac Biotech Co Ltd Conjugados de moléculas de unión celular con agentes citotóxicos
US9834575B2 (en) 2013-02-26 2017-12-05 Triact Therapeutics, Inc. Cancer therapy
US9499528B2 (en) 2013-04-08 2016-11-22 The University Of Akron Class of near infrared molecular probes for biological applications
DK3092256T3 (da) * 2014-01-10 2022-06-20 Birdie Biopharmaceuticals Inc Forbindelser og sammensætninger til immunterapi
KR101628872B1 (ko) * 2014-05-28 2016-06-09 주식회사 레고켐 바이오사이언스 자가-희생 기를 포함하는 화합물
WO2016029324A1 (en) 2014-08-29 2016-03-03 Rsem, Limited Partnership Azasulfurylpeptide-based cd36 modulators and uses thereof
US10035526B2 (en) 2014-12-03 2018-07-31 New York Air Brake, LLC Brake piston assembly
US10370407B2 (en) 2015-01-21 2019-08-06 The Regents Of The University Of California Affinity-assisted protein modification and recycling
CN107922375B (zh) 2015-07-30 2020-05-22 正大天晴药业集团股份有限公司 靶向idh2突变的抗肿瘤化合物及其使用方法
WO2017044043A1 (en) 2015-09-09 2017-03-16 Agency For Science, Technology And Research Process for direct amidation of amines via rh(i)-catalyzed addition of boroxines
KR101766822B1 (ko) 2015-09-10 2017-08-24 서울대학교산학협력단 디페닐설페이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 c형 간염 바이러스 관련 질환의 예방 또는 치료용 약학적 조성물
AU2016359235B2 (en) 2015-11-25 2022-09-15 Ligachem Biosciences Inc. Antibody-drug conjugates comprising branched linkers and methods related thereto
WO2018053552A2 (en) 2016-09-19 2018-03-22 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
WO2018124758A2 (ko) * 2016-12-28 2018-07-05 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
CN120682290A (zh) * 2017-07-04 2025-09-23 尹图赛利有限公司 包含可裂解接头的化合物及其用途
MX2020012718A (es) 2018-05-29 2021-02-16 Intocell Inc Derivados de benzodiazepinas novedosos y usos de los mismos.
CN112930350A (zh) 2018-10-31 2021-06-08 尹图赛利有限公司 稠合杂环苯并二氮杂䓬衍生物及其用途
WO2020141459A1 (en) 2019-01-03 2020-07-09 Intocell, Inc. Compounds comprising cleavable linker and uses thereof
KR20210099658A (ko) 2019-01-03 2021-08-12 주식회사 인투셀 절단가능 링커를 포함하는 화합물 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2022515885A5 (https=)
JP2020527599A5 (https=)
JP2022515884A5 (https=)
JP7744104B2 (ja) 部位特異的抗体コンジュゲーション及びその具体例としての抗体-薬物コンジュゲート
JP5695049B2 (ja) イマチニブ免疫アッセイ
CN114456186A (zh) 一种喜树碱类衍生物及其配体-药物偶联物
WO2017031034A2 (en) Covalent linkers in antibody-drug conjugates and methods of making and using the same
BR112020023346A2 (pt) anticorpo capaz de se ligar a muc1 e seu uso, ácido nucleico, cassete ou vetor de expressão, célula hospedeira, conjugado, composição, e, métodos para aumentar a afinidade de ligação a muc1 de um anticorpo e para produzir um anticorpo com afinidade de ligação a muc1 aumentada
KR20200041913A (ko) 면역자극제로서 톨-유사 수용체 7 (tlr7) 효능제로서의 6-아미노-7,9-디히드로-8h-퓨린-8-온 유도체
KR20200041914A (ko) 면역자극제 톨-유사 수용체 7 (tlr7) 효능제로서의 6-아미노-7,9-디히드로-8h-퓨린-8-온 유도체
EP2356131A1 (en) Masking ligands for reversible inhibition of multivalent compounds
CN111643676B (zh) 一种双特异性二聚体、双特异性二聚体-药物偶联物及其应用
CN105377307A (zh) 具有改进的稳定性的抗体-药物缀合物及其用途
KR102014383B1 (ko) G 단백질 연결 수용체의 활성 조절 인간 항체
Figini et al. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor
US20240059755A1 (en) Nanolipoprotein-polypeptide conjugates and compositions, systems, and methods using same
CN113490678A (zh) 荧光gtp类似物和用途
WO2023028548A2 (en) Bispecific tetravalent antibody targeting egfr and her3
JP2023165983A5 (https=)
Calce et al. HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor
RU2020104697A (ru) Соединения, содержащие расщепляемый линкер, и способы их применения
US10114014B2 (en) Macromolecular conjugates for isolation, immobilization and visualization of proteins
JP2025508868A5 (https=)
Hellmert et al. Hybridization of an Aβ-specific antibody fragment with aminopyrazole-based β-sheet ligands displays striking enhancement of target affinity
Colnaghi et al. Evolution of the therapeutic use of new monoclonal antibodies